Uneven genetic robustness of HIV-1 integrase

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 552-567

  Rihn, Suzannah J ^a   Hughes, Joseph ^b   Wilson, Sam J ^b   Bieniasz, Paul D ^a,c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIV 1 INTEGRASE; INTEGRASE; UNCLASSIFIED DRUG; GAG PROTEIN; MUTANT PROTEIN; P31 INTEGRASE PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE MAPPING; GENE MUTATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MORPHOGENESIS; MUTAGENESIS; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; VIRAL GENETICS; VIRION; VIRUS INFECTIVITY; VIRUS REPLICATION; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIAL VIABILITY; MISSENSE MUTATION; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

AMINO ACID SUBSTITUTION; HIV CORE PROTEIN P24; HIV INTEGRASE; HIV-1; MICROBIAL VIABILITY; MUTANT PROTEINS; MUTATION, MISSENSE;

EID: 84919430559     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02451-14     Document Type: Article

References (92)

1. Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S. 1982. Rapid evolution ofRNAgenomes. Science 215:1577-1585. http://dx.doi.org/10.1126/science.7041255.
2. Sanjuan R, Nebot MR, Chirico N, Mansky LM, Belshaw R. 2010. Viral mutation rates. J Virol 84:9733-9748. http://dx.doi.org/10.1128/JVI.00694-10.
3. Elena SF. 2012. RNA virus genetic robustness: possible causes and some consequences. Curr Opin Virol 2:525-530. http://dx.doi.org/10.1016/j.coviro.2012.06.008.
4. de Visser JA, Hermisson J, Wagner GP, Ancel Meyers L, Bagheri-Chaichian H, Blanchard JL, Chao L, Cheverud JM, Elena SF, Fontana W, Gibson G, Hansen TF, Krakauer D, Lewontin RC, Ofria C, Rice SH, von Dassow G, Wagner A, Whitlock MC. 2003. Perspective: evolution and detection of genetic robustness. Evolution 57:1959-1972. http://dx.doi.org/10.1111/j.0014-3820.2003.tb00377.x.
5. Lauring AS, Frydman J, Andino R. 2013. The role of mutational robustness in RNA virus evolution. Nat Rev Microbiol 11:327-336. http://dx.doi.org/10.1038/nrmicro3003.
6. Sanjuan R, Cuevas JM, Furio V, Holmes EC, Moya A. 2007. Selection for robustness in mutagenized RNA viruses. PLoS Genet 3:e93. http://dx.doi.org/10.1371/journal.pgen.0030093.
7. Codoner FM, Daros JA, Sole RV, Elena SF. 2006. The fittest versus the flattest: experimental confirmation of the quasispecies effect with subviral pathogens. PLoS Pathog 2:e136. http://dx.doi.org/10.1371/journal.ppat.0020136.
8. Montville R, Froissart R, Remold SK, Tenaillon O, Turner PE. 2005. Evolution of mutational robustness in an RNA virus. PLoS Biol 3:e381. http://dx.doi.org/10.1371/journal.pbio.0030381.
9. Sanjuan R, Moya A, Elena SF. 2004. The distribution of fitness effects caused by single-nucleotide substitutions in anRNAvirus. Proc Natl Acad Sci USA 101:8396-8401. http://dx.doi.org/10.1073/pnas.0400146101.
10. Carrasco P, de la Iglesia F, Elena SF. 2007. Distribution of fitness and virulence effects caused by single-nucleotide substitutions in tobacco etch virus. J Virol 81:12979-12984. http://dx.doi.org/10.1128/JVI.00524-07.
11. Rihn SJ, Wilson SJ, Loman NJ, Alim M, Bakker SE, Bhella D, Gifford RJ, Rixon FJ, Bieniasz PD. 2013. Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog 9:e1003461. http://dx.doi.org/10.1371/journal.ppat.1003461.
12. Miller MD, Farnet CM, Bushman FD. 1997. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 71:5382-5390.
13. Chen H, Engelman A. 2001. Asymmetric processing of human immunodeficiency virus type 1 cDNA in vivo: implications for functional end coupling during the chemical steps of DNA transposition. Mol Cell Biol 21: 6758-6767. http://dx.doi.org/10.1128/MCB.21.20.6758-6767.2001.
14. Wei SQ, Mizuuchi K, Craigie R. 1997. A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration. EMBO J 16:7511-7520. http://dx.doi.org/10.1093/emboj/16.24.7511.
15. Sherman PA, Fyfe JA. 1990. Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. Proc Natl Acad Sci USA 87:5119-5123. http://dx.doi.org/10.1073/pnas.87.13.5119.
16. Engelman A, Mizuuchi K, Craigie R. 1991. HIV-1 DNA integration: mechanism of viralDNAcleavage andDNAstrand transfer. Cell 67:1211-1221. http://dx.doi.org/10.1016/0092-8674(91)90297-C.
17. Bushman FD, Fujiwara T, Craigie R. 1990. Retroviral DNA integration directed by HIV integration protein in vitro. Science 249:1555-1558. http://dx.doi.org/10.1126/science.2171144.
18. Bushman FD, Craigie R. 1991. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc Natl Acad Sci USA 88:1339-1343. http://dx.doi.org/10.1073/pnas.88.4.1339.
19. Zheng R, Jenkins TM, Craigie R. 1996. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc Natl Acad Sci USA 93:13659-13664. http://dx.doi.org/10.1073/pnas.93.24.13659.
20. Kulkosky J, Jones KS, Katz RA, Mack JP, Skalka AM. 1992. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol 12:2331-2338.
21. Li X, Krishnan L, Cherepanov P, Engelman A. 2011. Structural biology of retroviral DNA integration. Virology 411:194-205. http://dx.doi.org/10.1016/j.virol.2010.12.008.
22. Dyda F, Hickman AB, Jenkins TM, Engelman A, Craigie R, Davies DR. 1994. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science 266:1981-1986. http://dx.doi.org/10.1126/science.7801124.
23. Woerner AM, Klutch M, Levin JG, Marcus-Sekura CJ. 1992. Localization of DNA binding activity of HIV-1 integrase to the C-terminal half of the protein. AIDS Res Hum Retroviruses 8:297-304. http://dx.doi.org/10.1089/aid.1992.8.297.
24. Eijkelenboom AP, Lutzke RA, Boelens R, Plasterk RH, Kaptein R, Hard K. 1995. The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nat Struct Biol 2:807-810. http://dx.doi.org/10.1038/nsb0995-807.
25. Guiot E, Carayon K, Delelis O, Simon F, Tauc P, Zubin E, Gottikh M, Mouscadet JF, Brochon JC, Deprez E. 2006. Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity. J Biol Chem 281:22707-22719. http://dx.doi.org/10.1074/jbc.M602198200.
26. Hare S, Gupta SS, Valkov E, Engelman A, Cherepanov P. 2010. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 464:232-236. http://dx.doi.org/10.1038/nature08784.
27. Maertens GN, Hare S, Cherepanov P. 2010. The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature 468: 326-329. http://dx.doi.org/10.1038/nature09517.
28. Johnson BC, Metifiot M, Ferris A, Pommier Y, Hughes SH. 2013. A homology model of HIV-1 integrase and analysis of mutations designed to test the model. J Mol Biol 425:2133-2146. http://dx.doi.org/10.1016/j.jmb.2013.03.027.
29. Krishnan L, Li X, Naraharisetty HL, Hare S, Cherepanov P, Engelman A. 2010. Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc Natl Acad Sci USA 107:15910-15915. http://dx.doi.org/10.1073/pnas.1002346107.
30. Engelman A. 1999. In vivo analysis of retroviral integrase structure and function. Adv Virus Res 52:411-426. http://dx.doi.org/10.1016/S0065-3527(08)60309-7.
31. Bushman FD, Engelman A, Palmer I, Wingfield P, Craigie R. 1993. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci USA 90:3428-3432. http://dx.doi.org/10.1073/pnas.90.8.3428.
32. Drelich M, Wilhelm R, Mous J. 1992. Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro. Virology 188:459-468. http://dx.doi.org/10.1016/0042-6822(92)90499-F.
33. Vink C, Oude Groeneger AM, Plasterk RH. 1993. Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res 21:1419-1425. http://dx.doi.org/10.1093/nar/21.6.1419.
34. Zheng Y, Ao Z, Jayappa KD, Yao X. 2010. Characterization of the HIV-1 integrase chromatin-and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase. Virol J 7:68. http://dx.doi.org/10.1186/1743-422X-7-68.
35. De Houwer S, Demeulemeester J, Thys W, Taltynov O, Zmajkovicova K, Christ F, Debyser Z. 2012. Identification of residues in the C-terminal domain of HIV-1 integrase that mediate binding to the transportin-SR2 protein. J Biol Chem 287:34059-34068. http://dx.doi.org/10.1074/jbc.M112.387944.
36. Yung E, Sorin M, Wang EJ, Perumal S, Ott D, Kalpana GV. 2004. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance. J Virol 78:2222-2231. http://dx.doi.org/10.1128/JVI.78.5.2222-2231.2004.
37. Wiskerchen M, Muesing MA. 1995. Identification and characterization of a temperature-sensitive mutant of human immunodeficiency virus type 1 by alanine scanning mutagenesis of the integrase gene. J Virol 69:597-601.
38. Engelman A, Craigie R. 1992. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol 66:6361-6369.
39. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. 1995. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 69:2729-2736.
40. Engelman A, Liu Y, Chen H, Farzan M, Dyda F. 1997. Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. J Virol 71:3507-3514.
41. Jenkins TM, Esposito D, Engelman A, Craigie R. 1997. Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J 16:6849-6859. http://dx.doi.org/10.1093/emboj/16.22.6849.
42. Chen JC, Krucinski J, Miercke LJ, Finer-Moore JS, Tang AH, Leavitt AD, Stroud RM. 2000. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc Natl Acad Sci USA 97:8233-8238. http://dx.doi.org/10.1073/pnas.150220297.
43. Cai M, Zheng R, Caffrey M, Craigie R, Clore GM, Gronenborn AM. 1997. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat Struct Biol 4:567-577. http://dx.doi.org/10.1038/nsb0797-567.
44. Johnson AA, Santos W, Pais GC, Marchand C, Amin R, Burke TR, Jr, Verdine G, Pommier Y. 2006. Integration requires a specific interaction of the donor DNA terminal 5'-cytosine with glutamine 148 of the HIV-1 integrase flexible loop. J Biol Chem 281:461-467. http://dx.doi.org/10.1074/jbc.M511348200.
45. Cahn P, Pozniak AL, Mingrone H, Shuldyakov A, Brites C, Andrade-Villanueva JF, Richmond G, Buendia CB, Fourie J, Ramgopal M, Hagins D, Felizarta F, Madruga J, Reuter T, Newman T, Small CB, Lombaard J, Grinsztejn B, Dorey D, Underwood M, Griffith S, Min S. 2013. Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, noninferiority SAILING study. Lancet 382:700-708. http://dx.doi.org/10.1016/S0140-6736(13)61221-0.
46. Bouyac-Bertoia M, Dvorin JD, Fouchier RA, Jenkins Y, Meyer BE, Wu LI, Emerman M, Malim MH. 2001. HIV-1 infection requires a functional integrase NLS. Mol Cell 7:1025-1035. http://dx.doi.org/10.1016/S1097-2765(01)00240-4.
47. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:1792-1797. http://dx.doi.org/10.1093/nar/gkh340.
48. Domingo-Calap P, Cuevas JM, Sanjuan R. 2009. The fitness effects of random mutations in single-stranded DNA and RNA bacteriophages. PLoS Genet 5:e1000742. http://dx.doi.org/10.1371/journal.pgen.1000742.
49. Cannon PM, Wilson W, Byles E, Kingsman SM, Kingsman AJ. 1994. Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues. J Virol 68:4768-4775.
50. Zhang F, Zang T, Wilson SJ, Johnson MC, Bieniasz PD. 2011. Clathrin facilitates the morphogenesis of retrovirus particles. PLoS Pathog 7:e1002119. http://dx.doi.org/10.1371/journal.ppat.1002119.
51. Wagner A. 2005. Robustness and evolvability in living systems. Princeton University Press, Princeton, NJ.
52. Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, Perno CF. 2009. Characterization and structural analysis of HIV-1 integrase conservation. AIDS Rev 11:17-29. http://www.aidsreviews.com/files/2009_11_1_017-029.pdf.
53. Loeb DD, Swanstrom R, Everitt L, Manchester M, Stamper SE, Hutchison CA, III. 1989. Complete mutagenesis of the HIV-1 protease. Nature 340:397-400. http://dx.doi.org/10.1038/340397a0.
54. Terwilliger TC, Zabin HB, Horvath MP, Sandberg WS, Schlunk PM. 1994. In vivo characterization of mutants of the bacteriophage f1 gene V protein isolated by saturation mutagenesis. J Mol Biol 236:556-571. http://dx.doi.org/10.1006/jmbi.1994.1165.
55. Suzutani T, Lacey SF, Powell KL, Purifoy DJ, Honess RW. 1992. Random mutagenesis of the thymidine kinase gene of varicella-zoster virus. J Virol 66:2118-2124.
56. Guo HH, Choe J, Loeb LA. 2004. Protein tolerance to random amino acid change. Proc Natl Acad Sci USA 101:9205-9210. http://dx.doi.org/10.1073/pnas.0403255101.
57. Ihssen J, Kowarik M, Wiesli L, Reiss R, Wacker M, Thony-Meyer L. 2012. Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB. BMC Biotechnol 12:67. http://dx.doi.org/10.1186/1472-6750-12-67.
58. Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD, Sundquist WI, Hill CP, Yeager M. 2009. X-ray structures of the hexameric building block of the HIV capsid. Cell 137:1282-1292. http://dx.doi.org/10.1016/j.cell.2009.04.063.
59. Briggs JA, Riches JD, Glass B, Bartonova V, Zanetti G, Krausslich HG. 2009. Structure and assembly of immature HIV. Proc Natl Acad Sci USA 106:11090-11095. http://dx.doi.org/10.1073/pnas.0903535106.
60. Forshey BM, von Schwedler U, Sundquist WI, Aiken C. 2002. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol 76:5667-5677. http://dx.doi.org/10.1128/JVI.76.11.5667-5677.2002.
61. Jouvenet N, Bieniasz PD, Simon SM. 2008. Imaging the biogenesis of individual HIV-1 virions in live cells. Nature 454:236-240. http://dx.doi.org/10.1038/nature06998.
62. Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, Roth SL, Hue S, Fletcher AJ, Lee K, KewalRamani VN, Noursadeghi M, Jenner RG, James LC, Bushman FD, Towers GJ. 2011. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog 7:e1002439. http://dx.doi.org/10.1371/journal.ppat.1002439.
63. Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP. 1993. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73:1067-1078.
64. Lee K, Mulky A, Yuen W, Martin TD, Meyerson NR, Choi L, Yu H, Sawyer SL, Kewalramani VN. 2012. HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6. J Virol 86:3851-3860. http://dx.doi.org/10.1128/JVI.06607-11.
65. Cherepanov P, Maertens G, Proost P, Devreese B, Van Beeumen J, Engelborghs Y, De Clercq E, Debyser Z. 2003. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 278:372-381. http://dx.doi.org/10.1074/jbc.M209278200.
66. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, Debyser Z, Engelborghs Y. 2003. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 278:33528-33539. http://dx.doi.org/10.1074/jbc.M303594200.
67. Christ F, Thys W, De Rijck J, Gijsbers R, Albanese A, Arosio D, Emiliani S, Rain JC, Benarous R, Cereseto A, Debyser Z. 2008. Transportin-SR2 imports HIV into the nucleus. Curr Biol 18:1192-1202. http://dx.doi.org/10.1016/j.cub.2008.07.079.
68. Morozov A, Yung E, Kalpana GV. 1998. Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region. Proc Natl Acad Sci U S A 95:1120-1125. http://dx.doi.org/10.1073/pnas.95.3.1120.
69. Kalpana GV, Goff SP. 1993. Genetic analysis of homomeric interactions of human immunodeficiency virus type 1 integrase using the yeast twohybrid system. Proc Natl Acad Sci USA 90:10593-10597. http://dx.doi.org/10.1073/pnas.90.22.10593.
70. Jenkins TM, Engelman A, Ghirlando R, Craigie R. 1996. A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxylterminal domains in multimerization. J Biol Chem 271:7712-7718. http://dx.doi.org/10.1074/jbc.271.13.7712.
71. Hare S, Di Nunzio F, Labeja A, Wang J, Engelman A, Cherepanov P. 2009. Structural basis for functional tetramerization of lentiviral integrase. PLoS Pathog 5:e1000515. http://dx.doi.org/10.1371/journal.ppat.1000515.
72. Sanjuan R, Borderia AV. 2011. Interplay between RNA structure and protein evolution in HIV-1. Mol Biol Evol 28:1333-1338. http://dx.doi.org/10.1093/molbev/msq329.
73. Zanini F, Neher RA. 2013. Quantifying selection against synonymous mutations in HIV-1 env evolution. J Virol 87:11843-11850. http://dx.doi.org/10.1128/JVI.01529-13.
74. ter Brake O, von Eije KJ, Berkhout B. 2008. Probing the sequence space available for HIV-1 evolution. AIDS 22:1875-1877. http://dx.doi.org/10.1097/QAD.0b013e328309efe3.
75. Knoepfel SA, Berkhout B. 2013. On the role of four small hairpins in the HIV-1 RNA genome. RNA Biol 10:540-552. http://dx.doi.org/10.4161/rna.24133.
76. Mayrose I, Stern A, Burdelova EO, Sabo Y, Laham-Karam N, Zamostiano R, Bacharach E, Pupko T. 2013. Synonymous site conservation in the HIV-1 genome. BMC Evol Biol 13:164. http://dx.doi.org/10.1186/1471-2148-13-164.
77. Woo J, Robertson DL, Lovell SC. 2010. Constraints on HIV-1 diversity from protein structure. J Virol 84:12995-13003. http://dx.doi.org/10.1128/JVI.00702-10.
78. Limon A, Devroe E, Lu R, Ghory HZ, Silver PA, Engelman A. 2002. Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import. J Virol 76:10598-10607. http://dx.doi.org/10.1128/JVI.76.21.10598-10607.2002.
79. Berthoux L, Sebastian S, Muesing MA, Luban J. 2007. The role of lysine 186 in HIV-1 integrase multimerization. Virology 364:227-236. http://dx.doi.org/10.1016/j.virol.2007.02.029.
80. Al-Mawsawi LQ, Hombrouck A, Dayam R, Debyser Z, Neamati N. 2008. Four-tiered pi interaction at the dimeric interface of HIV-1 integrase critical for DNA integration and viral infectivity. Virology 377:355-363. http://dx.doi.org/10.1016/j.virol.2008.04.030.
81. Serrao E, Thys W, Demeulemeester J, Al-Mawsawi LQ, Christ F, Debyser Z, Neamati N. 2012. A symmetric region of the HIV-1 integrase dimerization interface is essential for viral replication. PLoS One 7:e45177. http://dx.doi.org/10.1371/journal.pone.0045177.
82. Cherepanov P, Ambrosio AL, Rahman S, Ellenberger T, Engelman A. 2005. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc Natl Acad Sci USA 102:17308-17313. http://dx.doi.org/10.1073/pnas.0506924102.
83. Engelman A, Kessl JJ, Kvaratskhelia M. 2013. Allosteric inhibition of HIV-1 integrase activity. Curr Opin Chem Biol 17:339-345. http://dx.doi.org/10.1016/j.cbpa.2013.04.010.
84. Sharma A, Slaughter A, Jena N, Feng L, Kessl JJ, Fadel HJ, Malani N, Male F, Wu L, Poeschla E, Bushman FD, Fuchs JR, Kvaratskhelia M. 2014. A new class of multimerization selective inhibitors of HIV-1 integrase. PLoS Pathog 10:e1004171. http://dx.doi.org/10.1371/journal.ppat.1004171.
85. Perutz MF, Lehmann H. 1968. Molecular pathology of human haemoglobin. Nature 219:902-909. http://dx.doi.org/10.1038/219902a0.
86. Rodriguez WR, Addo MM, Rathod A, Fitzpatrick CA, Yu XG, Perkins B, Rosenberg ES, Altfeld M, Walker BD. 2004. CD8+ T lymphocyte responses target functionally important regions of protease and integrase in HIV-1 infected subjects. J Transl Med 2:15. http://dx.doi.org/10.1186/1479-5876-2-15.
87. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, Reddy S, de Pierres C, Mncube Z, Mkhwanazi N, Bishop K, van der Stok M, Nair K, Khan N, Crawford H, Payne R, Leslie A, Prado J, Prendergast A, Frater J, McCarthy N, Brander C, Learn GH, Nickle D, Rousseau C, Coovadia H, Mullins JI, Heckerman D, Walker BD, Goulder P. 2007. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13:46-53. http://dx.doi.org/10.1038/nm1520.
88. Brockman MA, Chopera DR, Olvera A, Brumme CJ, Sela J, Markle TJ, Martin E, Carlson JM, Le AQ, McGovern R, Cheung PK, Kelleher AD, Jessen H, Markowitz M, Rosenberg E, Frahm N, Sanchez J, Mallal S, John M, Harrigan PR, Heckerman D, Brander C, Walker BD, Brumme ZL. 2012. Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity. J Virol 86:6913-6923. http://dx.doi.org/10.1128/JVI.07133-11.
89. Crawford H, Matthews PC, Schaefer M, Carlson JM, Leslie A, Kilembe W, Allen S, Ndung'u T, Heckerman D, Hunter E, Goulder PJ. 2011. The hypervariable HIV-1 capsid protein residues comprise HLA-driven CD8+ T-cell escape mutations and covarying HLA-independent polymorphisms. J Virol 85:1384-1390. http://dx.doi.org/10.1128/JVI.01879-10.
90. Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, Rosato PC, Kadie CM, Carlson JM, Markle TJ, Streeck H, Kelleher AD, Markowitz M, Jessen H, Rosenberg E, Altfeld M, Harrigan PR, Heckerman D, Walker BD, Allen TM. 2010. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J Virol 84:11937-11949. http://dx.doi.org/10.1128/JVI.01086-10.
91. Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, Thobakgale C, Honeyborne I, Crawford H, Matthews P, Pillay T, Rousseau C, Mullins JI, Brander C, Walker BD, Stuart DI, Kiepiela P, Goulder P. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 80: 3617-3623. http://dx.doi.org/10.1128/JVI.80.7.3617-3623.2006.
92. McBride RC, Ogbunugafor CB, Turner PE. 2008. Robustness promotes evolvability of thermotolerance in an RNA virus. BMC Evol Biol 8:231. http://dx.doi.org/10.1186/1471-2148-8-231.